Actual Medicinal Product (AMP) Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (Accord-UK Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Store in airtight containers. Protect from light, moisture and freezing.
- Provenance
-
This compatibility recommendation is derived from CoAprovel 300mg/12.5mg tablets (Sanofi).
- Generic
- Irbesartan + Hydrochlorothiazide
- Formulation
- Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets
-
Irbesartan + Hydrochlorothiazide
-
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets
-
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (Accord-UK Ltd)
-
-